Delivery Order SPE2DB24D8001-SPE2DB25FKZCN

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical division was issued to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,589.50, is a firm fixed-price delivery order to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the DLA. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc., identified as SPE2DB24D8001, valued at $999,999,999.00. This...
This federal contract award, identified as SPE2DB24D8001|SPE2DB24FKZBU, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $2,062.35 firm fixed-price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product used to treat diabetes. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $1,250.46 firm fixed-price delivery order is for the provision of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract is an Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment,...
This federal contract award, identified as SPE2DB24D8003|SPE2DB24FJTHA, was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $1,451.00 firm fixed-price delivery order is for the provision of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award is associated with Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZCQ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a total ceiling value of $1,721.23. The contract is a Firm Fixed Price Delivery Order with a performance period extending through January 29, 2025. Dakota Drug, Inc. holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,348.37 firm-fixed-price delivery order is for the pharmaceutical product TRULICITY 4.5 MG/0.5 ML PEN 0.5ML. The award is associated with Dakota Drug's single-award Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and...
This federal contract award with ID SPE2DX15D8003|SPE2DX24F7B5P was issued by the Defense Logistics Agency (DLA), a defense agency, to Dakota Drug, Inc., a self-certified small disadvantaged business. The $8,757.92 firm fixed-price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This award is not part of a set-aside program. The contract has an ultimate completion date of November 3, 2023. Dakota Drug, Inc. holds a significant $999,999,999.00...
This federal contract award SPE2DX15D8002/SPE2DX24F2WJ0, with a ceiling value of $1,945.54, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This award is not a set-aside contract. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, contract SPE2DB24D8001, valued at...
This federal contract award, identified as SPE2DX15D8001|SPE2DX23FBQTU, was granted by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,448.49 firm fixed-price delivery order is for the provision of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This award is not set-aside and is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) SPE2DB24D8001 valued at...
This federal contract award, identified as SPE2DB24D8001|SPE2DB24FKYYM, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Dakota Drug, Inc. The $1,491.62 firm fixed-price delivery order is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product used to treat diabetes. Dakota Drug, Inc. is a self-certified small disadvantaged business that operates as a for-profit subchapter S corporation. The company has significant experience providing...
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB25FKZCN
    Delivery Order

This federal contract award, identified as SPE2DB24D8001 and SPE2DB25FKZCN, was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,523.49 firm fixed-price delivery order is for the provision of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product.

The award is part of Dakota Drug, Inc.'s existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to deliver a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This non-set-aside contract has a performance period extending through January 28, 2025.

Generated 4/28/25, 9:48 AM